These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 19033290)

  • 1. Optimal dosage and route of administration of methotrexate in rheumatoid arthritis: a systematic review of the literature.
    Visser K; van der Heijde D
    Ann Rheum Dis; 2009 Jul; 68(7):1094-9. PubMed ID: 19033290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methotrexate in rheumatoid arthritis: optimizing therapy among different formulations. Current and emerging paradigms.
    Cipriani P; Ruscitti P; Carubbi F; Liakouli V; Giacomelli R
    Clin Ther; 2014 Mar; 36(3):427-35. PubMed ID: 24612941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing methotrexate therapy in rheumatoid arthritis: a systematic literature review.
    Mouterde G; Baillet A; Gaujoux-Viala C; Cantagrel A; Wendling D; Le Loët X; Schaeverbeke T
    Joint Bone Spine; 2011 Dec; 78(6):587-92. PubMed ID: 21444233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate dosage as a source of bias in biological trials in rheumatoid arthritis: a systematic review.
    Durán J; Bockorny M; Dalal D; LaValley M; Felson DT
    Ann Rheum Dis; 2016 Sep; 75(9):1595-8. PubMed ID: 27091836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of non-steroidal anti-inflammatory drugs, including aspirin and paracetamol (acetaminophen) in people receiving methotrexate for inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis).
    Colebatch AN; Marks JL; Edwards CJ
    Cochrane Database Syst Rev; 2011 Nov; (11):CD008872. PubMed ID: 22071858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative.
    Visser K; Katchamart W; Loza E; Martinez-Lopez JA; Salliot C; Trudeau J; Bombardier C; Carmona L; van der Heijde D; Bijlsma JW; Boumpas DT; Canhao H; Edwards CJ; Hamuryudan V; Kvien TK; Leeb BF; Martín-Mola EM; Mielants H; Müller-Ladner U; Murphy G; Østergaard M; Pereira IA; Ramos-Remus C; Valentini G; Zochling J; Dougados M
    Ann Rheum Dis; 2009 Jul; 68(7):1086-93. PubMed ID: 19033291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recommendations for the use of methotrexate in rheumatoid arthritis: up and down scaling of the dose and administration routes.
    Tornero Molina J; Ballina García FJ; Calvo Alén J; Caracuel Ruiz MÁ; Carbonell Abelló J; López Meseguer A; Moreno Muelas JV; Pérez Sandoval T; Quijada Carrera J; Trenor Larraz P; Zea Mendoza A
    Reumatol Clin; 2015; 11(1):3-8. PubMed ID: 24746914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal methotrexate dose is associated with better clinical outcomes than non-optimal dose in daily practice: results from the ESPOIR early arthritis cohort.
    Gaujoux-Viala C; Rincheval N; Dougados M; Combe B; Fautrel B
    Ann Rheum Dis; 2017 Dec; 76(12):2054-2060. PubMed ID: 28866645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes related to methotrexate dose and route of administration in patients with rheumatoid arthritis: a systematic literature review.
    Goodman SM; Cronstein BN; Bykerk VP
    Clin Exp Rheumatol; 2015; 33(2):272-8. PubMed ID: 25536122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triple Oral Therapy Versus Antitumor Necrosis Factor Plus Methotrexate (MTX) in Patients with Rheumatoid Arthritis and Inadequate Response to MTX: A Systematic Literature Review.
    Mary J; De Bandt M; Lukas C; Morel J; Combe B
    J Rheumatol; 2017 Jun; 44(6):773-779. PubMed ID: 28412710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methotrexate and Rheumatoid Arthritis: Current Evidence Regarding Subcutaneous Versus Oral Routes of Administration.
    Bianchi G; Caporali R; Todoerti M; Mattana P
    Adv Ther; 2016 Mar; 33(3):369-78. PubMed ID: 26846283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.
    Chen YF; Jobanputra P; Barton P; Jowett S; Bryan S; Clark W; Fry-Smith A; Burls A
    Health Technol Assess; 2006 Nov; 10(42):iii-iv, xi-xiii, 1-229. PubMed ID: 17049139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recommendations for the use of parenteral methotrexate in rheumatic diseases.
    Tornero Molina J; Calvo Alen J; Ballina J; Belmonte MÁ; Blanco FJ; Caracuel MÁ; Carbonell J; Corominas H; Chamizo E; Hidalgo C; Ivorra JR; Marenco JL; Moreno Muelas JV; Muñoz-Fernández S; Nolla JM; Pérez T; Sanmarti R; Trenor P; Urrego C; Vidal J; Rosas Gomez de Salazar J
    Reumatol Clin (Engl Ed); 2018; 14(3):142-149. PubMed ID: 28082032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral Methotrexate in split dose weekly versus oral or parenteral Methotrexate once weekly in Rheumatoid Arthritis: a short-term study.
    Dhaon P; Das SK; Srivastava R; Agarwal G; Asthana A
    Int J Rheum Dis; 2018 May; 21(5):1010-1017. PubMed ID: 27455886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized controlled trial comparing 2 different starting doses of methotrexate in rheumatoid arthritis.
    Dhir V; Singla M; Gupta N; Goyal P; Sagar V; Sharma A; Khanna S; Singh S
    Clin Ther; 2014 Jul; 36(7):1005-15. PubMed ID: 24976447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methotrexate therapy for rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion.
    Pavy S; Constantin A; Pham T; Gossec L; Maillefert JF; Cantagrel A; Combe B; Flipo RM; Goupille P; Le Loët X; Mariette X; Puéchal X; Schaeverbeke T; Sibilia J; Tebib J; Wendling D; Dougados M
    Joint Bone Spine; 2006 Jul; 73(4):388-95. PubMed ID: 16626993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infliximab and methotrexate in the treatment of rheumatoid arthritis: a systematic review and meta-analysis of dosage regimens.
    Zintzaras E; Dahabreh IJ; Giannouli S; Voulgarelis M; Moutsopoulos HM
    Clin Ther; 2008 Nov; 30(11):1939-55. PubMed ID: 19108784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Security of the combined treatment of methotrexate and leflunomide in patients with rheumatoid arthritis].
    Nesa L; Gobbi C; Alba P; Exeni I; Babini A; Albiero E
    Rev Fac Cien Med Univ Nac Cordoba; 2007; 64(4):109-14. PubMed ID: 19928400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: results of a six-month, multicenter, randomized, double-blind, controlled, phase IV trial.
    Braun J; Kästner P; Flaxenberg P; Währisch J; Hanke P; Demary W; von Hinüber U; Rockwitz K; Heitz W; Pichlmeier U; Guimbal-Schmolck C; Brandt A;
    Arthritis Rheum; 2008 Jan; 58(1):73-81. PubMed ID: 18163521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of nonsteroidal antiinflammatory drugs and/or paracetamol in people receiving methotrexate for inflammatory arthritis: a Cochrane systematic review.
    Colebatch AN; Marks JL; van der Heijde DM; Edwards CJ
    J Rheumatol Suppl; 2012 Sep; 90():62-73. PubMed ID: 22942332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.